Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 7/20 | 0.45 |
| ▸ | CA1 | P00915 | 7/20 | 0.45 |
| ▸ | CA2 | P00918 | 7/20 | 0.45 |
| ▸ | CA9 | Q16790 | 7/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13427968 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL13402445 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL25985483 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL12083311 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL15494654 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL78636 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL12968777 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL62522 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL8602259 | 1.00 | HSD17B10 (0.47) | HSD17B10CYP2D6THRBMAPTCYP3A4 | |
| SCHEMBL7150795 | 0.92 | HSD17B10 (0.46) | HSD17B10CYP2D6THRBMAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4108262-A1 | CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAME | OSAKA UNIVERSITY (JP) | 2022-12-28 | — | — | EP | disclosed |
| US-9447133-B2 | Synthetic oligosaccharides for moraxella vaccine | Visterra, Inc. (US) | 2016-09-20 | — | — | US | disclosed |
| US-20140148592-A1 | Synthetic Oligosaccharides for Moraxella Vaccine | Visterra, Inc. | 2014-05-29 | — | — | US | disclosed |
| US-20130102759-A1 | Synthetic Oligosaccharides for Moraxella Vaccine | SYNGLYCO, INC. | 2013-04-25 | — | — | US | disclosed |
| US-8114970-B2 | Synthetic heparin monosaccharides | ALCHEMIA LIMITED (AU) | 2012-02-14 | — | — | US | disclosed |
| US-20100323976-A1 | NOVEL ANTI-INFLAMMATORY PRO-DRUGS | ACADEMISCH MEDISCH CENTRUM (NL) | 2010-12-23 | — | — | US | disclosed |
| US-20100222546-A1 | METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-09-02 | — | — | US | disclosed |
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | HPSE, DDOST, STT3A | HSD17B10 1735/4885CYP2D6 3080/4885THRB 2070/4885 |
| US-20130102759-A1 | Synthetic Oligosaccharides for Moraxella Vaccine | FUT6, OSTC, MGAM | HSD17B10 1808/4885CYP2D6 1577/4885THRB 3464/4885 |
| US-20140148592-A1 | Synthetic Oligosaccharides for Moraxella Vaccine | FUT6, FUT5, MGAM | HSD17B10 1839/4885CYP2D6 1845/4885THRB 3695/4885 |
| US-20100222546-A1 | METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES | PTMS, STT3A, GCG | HSD17B10 2692/4885CYP2D6 3438/4885THRB 3315/4885 |
| US-20100323976-A1 | NOVEL ANTI-INFLAMMATORY PRO-DRUGS | MSR1, ARG1, CD209 | HSD17B10 1992/4885CYP2D6 705/4885THRB 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.